Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Roskilde – page 82

1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Roskilde at a glance
1 178
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

1 178 trials in Roskilde

Open in trial search

Hidradenitis

Not recruiting

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Study on the Effects of Itepekimab on Airway Inflammation in Former Smokers with Chronic Obstructive Pulmonary Disease (COPD)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Anal cancer recurrent

Not recruiting

Study of Retifanlimab, Carboplatin, and Paclitaxel for Patients with Inoperable or Metastatic Anal Canal Squamous Cell Carcinoma Not Treated with Chemotherapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Incyte Corp.

Breast cancer

Not recruiting

Study of Trastuzumab Deruxtecan with or without Pertuzumab for Patients with HER2-positive Metastatic Breast Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB

Lymphoedema

Not recruiting

Study on Tacrolimus Ointment for Reducing Lymphedema in Breast Cancer Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Odense University Hospital

Study of Pariglasgene Brecaparvovec and Prednisolone for Adults with Glycogen Storage Disease Type Ia

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Ultragenyx Pharmaceutical Inc.

Huntington's disease

Not recruiting

Study on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Tominersen
  • Sponsor:F. Hoffmann-La Roche AG

Uveal melanoma+2

Not recruiting

Study on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Aura Biosciences Inc.

Neoplasm malignant

Not recruiting

A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Genmab A/S

Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

Plasma cell myeloma

Not recruiting

Study of Venetoclax, Daratumumab, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Corneal dystrophy

Not recruiting

Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ripasudil
  • Sponsor:Kowa Research Institute Inc.

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Roskilde

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.

  • Advanced cancer therapies
  • Immunotherapy combinations
  • Molecular response studies

Ongoing investigations into personalized treatment approaches for various cancer types.

02 Cardiovascular Studies

Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.

  • Prevention strategies
  • Risk reduction therapies
  • Innovative drug combinations

Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.

03 Immunology and Dermatology

Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.

  • Inflammatory skin conditions
  • Novel biological therapies
  • Treatment efficacy studies

Advancing treatment options for patients with moderate to severe skin conditions.

04 Infectious Disease Research

Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.

  • Vaccine development
  • Immunogenicity studies
  • Prevention strategies

Important research advancing preventive medicine and infection control.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.